Proposal for including risk of malignancy and clinical management in the Japanese system for reporting thyroid cytopathology - A multi-institutional study
Overall, this study determines the frequency, ROM, and recommended clinical management for thyroid cytopathology in Japan. These results were different from those proposed by the Bethesda System for Reporting Thyroid Cytopathology. In the future, our results will be helpful in the revision of JSRTC and will contribute to improving the outcomes among Japanese patients with thyroid nodules.
Authors
- Ryohei Katoh
- Takashi Amano (ORCID: https://orcid.org/0000-0003-1270-5019)
- Miyoko Higuchi (ORCID: https://orcid.org/0000-0001-8262-2652)
- Naoko Yamazaki
- Mitsuyoshi Hirokawa (ORCID: https://orcid.org/0000-0001-5558-7142)
- Takashi Akamizu (ORCID: https://orcid.org/0000-0003-4960-8271)
- Tomohiro Chiba (ORCID: https://orcid.org/0000-0003-4374-9997)
- Eiji Sasaki (ORCID: https://orcid.org/0000-0002-4859-8473)
- Yasuyo Ohi
- Ayana Suzuki (ORCID: https://orcid.org/0000-0002-0827-1580)
- Hironao Yasuoka (ORCID: https://orcid.org/0009-0005-5553-9729)
- Yukari Maeda
- Shinya Satoh (ORCID: https://orcid.org/0000-0002-0761-6209)
- Mitsuhiro Fukushima
- Miyuki Towata
Institutions
- SHOWA Medical University Northern Yokohama Hospital (JP)
- Ito Hospital (JP)
- Osaka Rosai Hospital (JP)
- National Sagamihara Hospital (JP)
- Shibuya (Japan) (JP)
- Kuma Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
- Yamashita Thyroid Hospital
Publication Details
- Journal
- CytoJournal
- Published
- 2025-05-15
- DOI
- https://doi.org/10.25259/cytojournal_229_2024
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.29